The evolution of drug development, from ancient herbal remedies to modern intelligent drugs, reflects a profound transformation in medical science. This journey can be divided into the magical-empirical practices of antiquity, the emergence of modern pharmaceuticals through scientific inquiry, and the recent advancements driven by biotechnologies. By the late twentieth century, biotechnology introduced a new class of biological drugs, revolutionizing treatment options for diseases like HIV and hepatitis C. The integration of molecular biology into medicine has enabled precise diagnostics and targeted therapies, significantly improving patient outcomes. Intelligent drugs powered by AI are transforming precision medicine by targeting specific biological processes and patient characteristics, enhancing treatment efficacy and safety. These innovations leverage predictive models to design drugs that minimize unwanted interactions. Initially successful in oncology, precision medicine is expanding across medical fields, offering personalized treatments based on genetic profiles. This growth is part of a broader knowledge economy where technological advancements drive innovation and economic development, with the health industry playing a central role in creating societal wealth through substantial R&D investments.